Inquiries / Themes / Hospital and clinical care

Infected blood and blood safety

Infected blood and blood products, transfusion safety, the Infected Blood Inquiry and its compensation scheme.

72 inquiry recommendations

Public inquiry recommendations

What public inquiries recommended · 72 recommendations

Jump to year: 2025 2024 2023 2022 2015

2025

Infected Blood Inquiry Recommendation AC-2c
9 Jul 2025
Addressed to Infected Blood Compensation Authority

A formal role be given within IBCA for an advisory body consisting of people infected and affected, covering a range of experience broadly representative of those groups, and (if those groups so wish) including clinicians covering the major relevant disciplines of hepatitis and liver disease, HIV, transfusion,…

Infected Blood Inquiry Recommendation AC-1d
9 Jul 2025
Addressed to Infected Blood Compensation Authority

When IBCA opens up the service beyond people infected and registered with the support schemes, IBCA: (i) update the sequencing to three cohorts, people infected and never compensated, the deceased infected, and people affected and (ii) adopt a scheme of prioritisation within each cohort which can be objectively…

Infected Blood Inquiry Recommendation AC-1b
9 Jul 2025
Addressed to Infected Blood Compensation Authority

There be forms (devised by IBCA) for people to register and apply for a core award and the supplementary awards with/without the necessary evidence and with/without calculation of compensation, and as an intermediate step that IBCA provide the option to move straight to the declaration stage for individuals providing…

Infected Blood Inquiry Recommendation AC-1a
9 Jul 2025
Addressed to Infected Blood Compensation Authority

The scheme be opened to registration to everyone who may be eligible.

Infected Blood Inquiry Recommendation IBI-A-9a
9 Jul 2025
Addressed to UK Government

The IBSS cut-off date of 31 March 2025 be reviewed, that the scheme should as soon as possible reinstate support payments to partners bereaved after 31 March 2025 until such time as they receive compensation and that they should have a continuation of those payments as an option in their compensation package.

Infected Blood Inquiry Recommendation IBI-A-8b
9 Jul 2025
Addressed to UK Government

The Regulations be amended such that where someone who would be an eligible affected person dies between 21 May 2024 and 31 December 2029, their claim does not die with them but becomes part of their estate.

Infected Blood Inquiry Recommendation IBI-A-8a
9 Jul 2025
Addressed to UK Government

The Minister give consideration to there being a supplementary route for people affected. This could include opening the supplemental award for severe psychological harm to people affected. He should involve parents, children, siblings, partners and carers, and their legal representatives if wished, in this…

Infected Blood Inquiry Recommendation IBI-A-7a
9 Jul 2025
Addressed to UK Government

Where there is evidence that an individual was the victim of unethical research practices IBCA should be authorised to make an unethical research practices award to that individual.

Infected Blood Inquiry Recommendation IBI-A-6b
9 Jul 2025
Addressed to UK Government

The Cabinet Office consult on whether the evidential requirements for exceptional reduced earnings are likely to prove a barrier to people who have sufficient evidence that their eligibility for such an award could with confidence be established on a balance of probabilities, and if so to consider what if any…

Infected Blood Inquiry Recommendation IBI-A-6a
9 Jul 2025
Addressed to UK Government

"x" be removed from the equation set out in Regulation 7.

Infected Blood Inquiry Recommendation IBI-A-5a
9 Jul 2025
Addressed to UK Government

The approach of the Infected Blood Psychology Service is adopted so that both a diagnosis made by a psychiatric professional and a formulation-based opinion of all qualified psychological and counselling professionals are accepted as sufficient evidence of severe psychological harm and that such evidence should…

Infected Blood Inquiry Recommendation IBI-A-4e
9 Jul 2025
Addressed to UK Government

Regulation 14(2)(c) be amended to remove the requirement for evidence of the date of diagnosis of Hepatitis B or C. An appropriate redraft to achieve this would be: "where the diagnosis mentioned in sub-paragraph (a) is one of HIV, the date on which it was given."

Infected Blood Inquiry Recommendation IBI-A-4d
9 Jul 2025
Addressed to UK Government

Where the level of severity of a person's infection at Level 3 or more has been established to IBCA's satisfaction in relation to a given year, but it is not known when it reached Level 3 or more, the legislative provisions should apply to deem the level of severity in the years which preceded that given year.

Infected Blood Inquiry Recommendation IBI-A-4c
9 Jul 2025
Addressed to UK Government

For the calculation of Financial Loss awards for Hepatitis B, people born after 1953 should be treated like those born in or before 1953 on provision of evidence that their health did not improve or that it remained difficult to find work from 2009. For the calculation of Financial Loss awards for Hepatitis C, people…

Infected Blood Inquiry Recommendation IBI-A-4b
9 Jul 2025
Addressed to UK Government

The Government reconsider whether to maintain its rejection in February 2025 of the recommendations of Sir [name] KC and advice from the Infected Blood Inquiry Response Expert Group of August 2024, which was expressly accepted at the time by the Government, to introduce (as one of six health impact groups which would…

Infected Blood Inquiry Recommendation IBI-A-4a
9 Jul 2025
Addressed to UK Government

People infected with Hepatitis B or C who have received a course of treatment with or based on interferon should be recognised as entitled to core awards at Level 3.

Infected Blood Inquiry Recommendation IBI-A-3a
9 Jul 2025
Addressed to UK Government

An amendment to the Regulations be made as soon as possible to remove the reference to 1 January 1982 from Regulation 3.

Infected Blood Inquiry Recommendation IBI-A-2e
9 Jul 2025
Addressed to UK Government

The Government and IBCA establish a mechanism by which individuals or organisations may raise concerns which arise about any aspect of the scheme which from time to time is troubling them. The mechanism is intended to help continuous improvement of, and/or aid understanding of, any aspect of the scheme. It should…

2024

Infected Blood Inquiry Recommendation IBI-10a(v)
20 May 2024
Addressed to UK Government

Steps be taken to give greater prominence to the online Yellow Card system to those receiving drugs or biological products, or who are being transfused with blood components.

Infected Blood Inquiry Recommendation IBI-10a(iv)
20 May 2024
Addressed to UK Government

Particular consideration be given, together with the UK Thalassaemia Society and the Sickle Cell Society, to how the needs of patients with thalassaemia or sickle cell disease can best holistically be addressed.

Infected Blood Inquiry Recommendation IBI-10a(iii)
20 May 2024
Addressed to UK Government

That favourable consideration be given to other charities and organisations supporting people infected and affected that were granted core participant status (as listed on the Inquiry website) to continue to provide support for at least the next 18 months. Further support should be reviewed at that stage with a view…

Infected Blood Inquiry Recommendation IBI-10a(ii)
20 May 2024
Addressed to UK Government

That the following charities receive funding specifically for patient advocacy: the UK Haemophilia Society; the Hepatitis C Trust; Haemophilia Scotland; the Scottish Infected Blood Forum; Haemophilia Wales; Haemophilia Northern Ireland; and the UK Thalassaemia Society.

Infected Blood Inquiry Recommendation IBI-9f
20 May 2024
Addressed to UK Government

That the National Haemophilia Database, run by the UKHCDO, merits the support of additional central funding.

Infected Blood Inquiry Recommendation IBI-9e
20 May 2024
Addressed to UK Government

Recombinant coagulation factor products should be offered in place of plasma-derived ones where clinically appropriate. Service commissioners should ensure that such treatment decisions are funded accordingly.

Infected Blood Inquiry Recommendation IBI-9d
20 May 2024
Addressed to UK Government

The necessary administrative and clinical resources should be provided by hospital trusts and boards, integrated care boards, and service commissioners to facilitate multi-disciplinary regional networks to discuss policy and practice in haemophilia and other inherited bleeding disorders care, provided they involve…

Page 1 of 3 Next

Every record on this page is an inquiry recommendation published by the inquiry named on its card, and each card links to the recommendation. The themes, and which recommendations sit under each, are our own classification.

Licensing and attribution for every source